Journal of Signal Transduction [176] P. Delafontaine and L. Ku, “Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells,” Cardiovascular Research, vol. 33, no. 1, pp. 216– 222, 1997. [177] P. Delafontaine, Y. H. Song, and Y. Li, “Expression, regu- lation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels,” Arteriosclerosis, Thrombosis and Vascular Biology, vol. 24, no. 3, pp. 435–444, 2004. [178] A.-E. Handayaningsih, G. Iguchi, H. Fukuoka et al., “Reactive oxygen species play an essential role in IGF-I signaling and IGF-I-induced myocyte hypertrophy in C2C12 myocytes,” Endocrinology, vol. 152, no. 3, pp. 912–921, 2011. [179] P. T. Diaz, Z. W. She, W. B. Davis, and T. L. Clanton, “Hydroxylation of salicylate by the in vitro diaphragm: evidence for hydroxyl radical production during fatigue,” Journal of Applied Physiology, vol. 75, no. 2, pp. 540–545, 1993. [180] M. B. Reid, K. E. Haack, K. M. Franchek, P. A. Valberg, L. Kobzik, and M. S. West, “Reactive oxygen in skeletal muscle. I. Intracellular oxidant kinetics and fatigue in vitro,” Journal of Applied Physiology, vol. 73, no. 5, pp. 1797–1804, 1992. [181] L. Zuo, F. L. Christoﬁ, V. P. Wright et al., “Intra- and extra- cellular measurement of reactive oxygen species produced during heat stress in diaphragm muscle,” American Journal of Physiology—Cell Physiology, vol. 279, no. 4, pp. C1058– C1066, 2000. [182] D. J. Falk, K. C. DeRuisseau, D. L. Van Gammeren, M. A. Deering, A. N. Kavazis, and S. K. Powers, “Mechanical ven- tilation promotes redox status alterations in the diaphragm,” Journal of Applied Physiology, vol. 101, no. 4, pp. 1017–1024, 2006. [183] L. Zuo and T. L. Clanton, “Reactive oxygen species formation in the transition to hypoxia in skeletal muscle,” American Journal of Physiology—Cell Physiology, vol. 289, no. 1, pp. C207–C216, 2005. [184] A. S. Martins, V. M. Shkryl, M. C. Nowycky, and N. Shirokova, “Reactive oxygen species contribute to Ca2+ signals produced by osmotic stress in mouse skeletal muscle ﬁbres,” Journal of Physiology, vol. 586, no. 1, pp. 197–210, 2008. [185] W. Cheng, B. Li, J. Kajstura et al., “Stretch-induced pro- grammed myocyte cell death,” Journal of Clinical Investiga- tion, vol. 96, no. 5, pp. 2247–2259, 1995. [186] A. Espinosa, A. Garc´ıa, S. Ha¨rtel, C. Hidalgo, and E. Jaimovich, “NADPH oxidase and hydrogen peroxide mediate insulin-induced calcium increase in skeletal muscle cells,” Journal of Biological Chemistry, vol. 284, no. 4, pp. 2568– 2575, 2009. [187] V. Goossens, J. Grooten, K. De Vos, and W. Fiers, “Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 18, pp. 8115–8119, 1995. [188] V. J. Thannickal and B. L. Fanburg, “Reactive oxygen species in cell signaling,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 279, no. 6, pp. L1005– L1028, 2000. [189] Q. Felty, W. C. Xiong, D. Sun et al., “Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers,” Biochemistry, vol. 44, no. 18, pp. 6900–6909, 2005. [190] A. Zhang, Z. Jia, X. Guo, and T. Yang, “Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial 17 origin,” American Journal of Physiology—Renal Physiology, vol. 293, no. 3, pp. F723–F731, 2007. [191] V. P. Wright, P. J. Reiser, and T. L. Clanton, “Redox modulation of global phosphatase activity and protein phos- phorylation in intact skeletal muscle,” Journal of Physiology, vol. 587, part 23, pp. 5767–5781, 2009. [192] D. Hecht and Y. Zick, “Selective inhibition of protein tyrosine phosphatase activities by H2O2 and vanadate in vitro,” Biochemical and Biophysical Research Communications, vol. 188, no. 2, pp. 773–779, 1992. [193] D. Heﬀetz, I. Bushkin, R. Dror, and Y. Zick, “The insuli- nomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells,” Journal of Biological Chemistry, vol. 265, no. 5, pp. 2896–2902, 1990. [194] A. Agbas, D. Hui, X. Wang, V. Tek, A. Zaidi, and E. K. Michaelis, “Activation of brain calcineurin (Cn) by Cu-Zn superoxide dismutase (SOD1) depends on direct SOD1- Cn protein interactions occurring in vitro and in vivo,” Biochemical Journal, vol. 405, no. 1, pp. 51–59, 2007. [195] D. Namgaladze, H. W. Hofer, and V. Ullrich, “Redox control of calcineurin by targeting the binuclear Fe2+-Zn2+ center at the enzyme active site,” Journal of Biological Chemistry, vol. 277, no. 8, pp. 5962–5969, 2002. [196] D. Namgaladze, I. Shcherbyna, J. Kienho¨fer, H. W. Hofer, and V. Ullrich, “Superoxide targets calcineurin signaling in vascular endothelium,” Biochemical and Biophysical Research Communications, vol. 334, no. 4, pp. 1061–1067, 2005. [197] S. K. Powers, A. N. Kavazis, and K. C. DeRuisseau, “Mech- anisms of disuse muscle atrophy: role of oxidative stress,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 288, no. 2, pp. R337–R344, 2005. [198] S. K. Powers, A. N. Kavazis, and J. M. McClung, “Oxidative stress and disuse muscle atrophy,” Journal of Applied Physiol- ogy, vol. 102, no. 6, pp. 2389–2397, 2007. [199] K. L. Hamilton, J. L. Staib, T. Phillips, A. Hess, S. L. Lennon, and S. K. Powers, “Exercise, antioxidants, and HSP72: protection against myocardial ischemia/reperfusion,” Free Radical Biology and Medicine, vol. 34, no. 7, pp. 800–809, 2003. [200] M. Ristow, K. Zarse, A. Oberbach et al., “Antioxidants prevent health-promoting eﬀects of physical exercise in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 21, pp. 8665–8670, 2009.